Bridgefront Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$163K Buy
+12,067
New +$144K 0.04% 469
2026
Q1
Sell
-65,932
Closed -$473K 698
2025
Q4
$473K Buy
65,932
+55,214
+515% +$436K 0.12% 285
2025
Q3
$114K Sell
10,718
-56,825
-84% -$558K 0.03% 556
2025
Q2
$654K Buy
67,543
+56,439
+508% +$582K 0.17% 206
2025
Q1
$165K Buy
+11,104
New +$171K 0.05% 549
2024
Q4
Sell
-19,535
Closed -$374K 727
2024
Q3
$374K Buy
+19,535
New +$405K 0.14% 264
2023
Q4
Sell
-10,079
Closed -$175K 512
2023
Q3
$175K Buy
+10,079
New +$210K 0.12% 327
2023
Q2
Sell
-9,807
Closed -$231K 607
2023
Q1
$231K Buy
+9,807
New +$263K 0.14% 294

Other funds holding OGN

Bridgefront Capital's OGN Position: Q2 2026 in Review

Bridgefront Capital opened a new position in Organon & Co (OGN) in Q2 2026: 12,067 shares worth $163K. The stake represents 0.04% of the portfolio and ranks #469 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in OGN as recently as Q4 2025.

Bridgefront Capital first reported a position in OGN in Q1 2023 and has held it in 8 quarters since. The position peaked at $654K in Q2 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Bridgefront Capital held 12,067 shares of Organon & Co worth $163K as of Q2 2026.
  • Organon & Co was a new Bridgefront Capital position in Q2 2026.
  • Organon & Co made up 0.04% of Bridgefront Capital's portfolio in Q2 2026, its #469 holding.
  • Bridgefront Capital first reported a position in Organon & Co in Q1 2023 and has held it in 8 quarters since.
  • Bridgefront Capital's Organon & Co position peaked at $654K in Q2 2025.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.